Michael L Peterson insider trades: TRxADE HEALTH (MEDS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
and 4 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 21, 2021 | MEDS | ↓ Sell | 900 | $4.45 | $4K | Direct | Jun 22, 2021 (1d) |
| Apr 19, 2021 | MEDS | ↓ Sell | 900 | $4.68 | $4K | Direct | Apr 20, 2021 (1d) |
| Dec 14, 2020 | MEDS | ↓ Sell10b5-1 | 1,800 | $5.26 | $9K | Direct | Dec 15, 2020 (1d) |
| Jun 28, 2018 | PED | ↓ Sell10b5-1 | 119,000 | $2.96 | $352K | Direct | Jun 29, 2018 (1d) |
| Dec 28, 2017 | PED | ↓ Sell10b5-1 | 24,750 | $0.31 | $8K | Direct | Dec 29, 2017 (1d) |
| Oct 9, 2017 | PED | ↓ Sell10b5-1 | 1,500 | $0.39 | $586 | Direct | Oct 11, 2017 (2d) |
| Jul 10, 2017 | PED | ↓ Sell10b5-1 | 8,048 | $0.61 | $5K | Direct | Jul 10, 2017 (0d) |
| Jun 30, 2017 | PED | ↓ Sell10b5-1 | 41,250 | $0.62 | $26K | Direct | Jun 30, 2017 (0d) |
| Apr 10, 2017 | PED | ↓ Sell10b5-1 | 1,500 | $1.11 | $2K | Direct | Apr 11, 2017 (1d) |
| Jan 11, 2017 | PED | ↓ Sell10b5-1 | 142,250 | $0.10 | $15K | Direct | Jan 11, 2017 (0d) |
| Oct 10, 2016 | PED | ↓ Sell10b5-1 | 15,000 | $0.18 | $3K | Direct | Oct 12, 2016 (2d) |
| Sep 7, 2016 | PED | ↓ Sell10b5-1 | 32,500 | $0.17 | $6K | Direct | Sep 9, 2016 (2d) |
| Aug 9, 2016 | PED | ↓ Sell10b5-1 | 24,375 | $0.22 | $5K | Direct | Aug 11, 2016 (2d) |
| Jul 11, 2016 | PED | ↓ Sell10b5-1 | 168,565 | $0.24 | $41K | Direct | Jul 11, 2016 (0d) |
| Apr 8, 2015 | PED | ↓ Sell10b5-1 | 20,000 | $0.52 | $10K | Direct | Apr 10, 2015 (2d) |
| Apr 2, 2015 | PED | ↓ Sell10b5-1 | 39,500 | $0.58 | $23K | Direct | Apr 3, 2015 (1d) |
| Feb 9, 2015 | PED | ↓ Sell10b5-1 | 24,375 | $0.60 | $15K | Direct | Feb 10, 2015 (1d) |
| Jan 5, 2015 | PED | ↓ Sell10b5-1 | 39,500 | $0.41 | $16K | Direct | Jan 7, 2015 (2d) |
| Aug 29, 2014 | PED | ↓ Sell10b5-1 | 3,500 | $2.00 | $7K | Direct | Sep 3, 2014 (5d) |
| Jul 1, 2014 | PED | ↓ Sell10b5-1 | 9,000 | $2.07 | $19K | Direct | Jul 3, 2014 (2d) |
| Feb 10, 2014 | PED | ↓ Sell10b5-1 | 65,000 | $2.09 | $136K | Direct | Feb 12, 2014 (2d) |
| Sep 11, 2013 | PED | ↓ Sell10b5-1 | 3,234 | $4.50 | $15K | Direct | Sep 11, 2013 (0d) |
| Sep 6, 2013 | PEDO | ↓ Sell10b5-1 | 5,100 | $4.50 | $23K | Direct | Sep 9, 2013 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael L Peterson's insider trades
Michael L Peterson is a director at TRxADE HEALTH (MEDS). Since Sep 6, 2013, Michael has reported no open-market purchases and 23 sales worth $743K on SEC Form 4. There have been no open-market trades in the last 12 months.
21 sales (99% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (19 filings), gifts (12 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEDS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.